Literature DB >> 30475229

Rejuvenation of β cells by epigenetic editing.

Tao Wang1,2,3, Duanqing Pei1,2,3,4.   

Abstract

Insulin-secreting β cell loss or dysfunction is a feature of both type 1 and type 2 diabetes. Strategies to restore β cell mass are limited, as sources of healthy islets are scarce and mature β cells are not readily expanded in vitro. In this issue of the JCI, Ou et al. report that mature β cell expansion can be induced in situ through epigenetic editing of regulatory elements in pancreatic tissue. Specifically, hypomethylation at imprinting control region 2 (ICR2) in human islets promoted β cell expansion. Importantly, transplantation of these epigenetically edited islets into diabetic mice reduced blood glucose levels. Together, these results support further evaluation of this strategy for restoring β cell mass in patients with diabetes.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30475229      PMCID: PMC6307952          DOI: 10.1172/JCI124583

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  12 in total

Review 1.  DNA methylation patterns and epigenetic memory.

Authors:  Adrian Bird
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

Review 2.  A decade of exploring the cancer epigenome - biological and translational implications.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

Review 3.  Aberrant DNA Methylation in Colorectal Cancer: What Should We Target?

Authors:  Janson W T Tse; Laura J Jenkins; Fiona Chionh; John M Mariadason
Journal:  Trends Cancer       Date:  2017-09-12

4.  p16INK4a induces an age-dependent decline in islet regenerative potential.

Authors:  Janakiraman Krishnamurthy; Matthew R Ramsey; Keith L Ligon; Chad Torrice; Angela Koh; Susan Bonner-Weir; Norman E Sharpless
Journal:  Nature       Date:  2006-09-06       Impact factor: 49.962

5.  Targeted demethylation at the CDKN1C/p57 locus induces human β cell replication.

Authors:  Kristy Ou; Ming Yu; Nicholas G Moss; Yue J Wang; Amber W Wang; Son C Nguyen; Connie Jiang; Eseye Feleke; Vasumathi Kameswaran; Eric F Joyce; Ali Naji; Benjamin Glaser; Dana Avrahami; Klaus H Kaestner
Journal:  J Clin Invest       Date:  2018-11-26       Impact factor: 14.808

6.  Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss.

Authors:  Fabrizio Thorel; Virginie Népote; Isabelle Avril; Kenji Kohno; Renaud Desgraz; Simona Chera; Pedro L Herrera
Journal:  Nature       Date:  2010-04-04       Impact factor: 49.962

Review 7.  DNA Methylation in Cancer and Aging.

Authors:  Michael Klutstein; Deborah Nejman; Razi Greenfield; Howard Cedar
Journal:  Cancer Res       Date:  2016-06-02       Impact factor: 12.701

8.  Congenital hyperinsulinism in children with paternal 11p uniparental isodisomy and Beckwith-Wiedemann syndrome.

Authors:  Jennifer M Kalish; Kara E Boodhansingh; Tricia R Bhatti; Arupa Ganguly; Laura K Conlin; Susan A Becker; Stephanie Givler; Lindsey Mighion; Andrew A Palladino; N Scott Adzick; Diva D De León; Charles A Stanley; Matthew A Deardorff
Journal:  J Med Genet       Date:  2015-11-06       Impact factor: 6.318

9.  Reprogramming to pluripotency using designer TALE transcription factors targeting enhancers.

Authors:  Xuefei Gao; Jian Yang; Jason C H Tsang; Jolene Ooi; Donghai Wu; Pentao Liu
Journal:  Stem Cell Reports       Date:  2013-07-11       Impact factor: 7.765

10.  Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins.

Authors:  Morgan L Maeder; James F Angstman; Marcy E Richardson; Samantha J Linder; Vincent M Cascio; Shengdar Q Tsai; Quan H Ho; Jeffry D Sander; Deepak Reyon; Bradley E Bernstein; Joseph F Costello; Miles F Wilkinson; J Keith Joung
Journal:  Nat Biotechnol       Date:  2013-10-09       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.